{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:22:31Z","timestamp":1778181751343,"version":"3.51.4"},"reference-count":51,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"published-print":{"date-parts":[[2025,8,9]]},"DOI":"10.1080\/14737167.2025.2522326","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:27:56Z","timestamp":1750217276000},"page":"1011-1020","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the upper bound of survival for conducting and critically appraising economic evaluations of low-risk cancers"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-8233","authenticated-orcid":false,"given":"Xuanqian","family":"Xie","sequence":"first","affiliation":[{"name":"Ontario Health","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Joshi","sequence":"additional","affiliation":[{"name":"Ontario Health","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra","family":"Wang","sequence":"additional","affiliation":[{"name":"Ontario Health","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[{"name":"Ontario Health","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"issue":"9","key":"e_1_3_9_4_1","first-page":"10","article-title":"Progress in net cancer survival in Canada over 20 years","volume":"29","author":"Ellison LF.","year":"2018","unstructured":"Ellison LF. Progress in net cancer survival in Canada over 20 years. Health Rep. 2018;29(9):10\u201318.","journal-title":"Health Rep"},{"key":"e_1_3_9_5_1","unstructured":"National Cancer Institute at the National Institutes of Health (US). National cancer institute dictionary of cancer terms: low-risk cancer. Bethesda (MD); [cited 2025 Apr 21]. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/low-risk-cancer"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1703787"},{"key":"#cr-split#-e_1_3_9_7_1.1","unstructured":"American Cancer Society. Thyroid cancer survival rates by type and stage. Atlanta (GA). [updated 2024 Aug 23"},{"key":"#cr-split#-e_1_3_9_7_1.2","unstructured":"cited 2025 Apr 21]. Available from: https:\/\/www.cancer.org\/cancer\/thyroid-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"key":"#cr-split#-e_1_3_9_8_1.1","unstructured":"American Cancer Society. Survival rates for prostate cancer. Atlanta (GA). [updated 2025 Jan 16"},{"key":"#cr-split#-e_1_3_9_8_1.2","unstructured":"cited 2025 Apr 21]. Available from: https:\/\/www.cancer.org\/cancer\/prostate-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38737.607558.80"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1781-z"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462311000511"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu024"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0211"},{"key":"e_1_3_9_14_1","unstructured":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society Statistics Canada and the Public Health Agency of Canada. Canadian cancer statistics 2023 [internet]. Toronto (ON): Canadian Cancer Society; 2023 [cited 2024 Feb 18]. Available from: cancer.ca\/Canadian-Cancer-Statistics-2023-EN"},{"key":"#cr-split#-e_1_3_9_15_1.1","unstructured":"American Cancer Society. Survival rates for breast cancer. Atlanta (GA). [updated 2025 Jan 16"},{"key":"#cr-split#-e_1_3_9_15_1.2","unstructured":"cited 2025 Apr 21]. Available from: https:\/\/www.cancer.org\/cancer\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html"},{"key":"e_1_3_9_16_1","unstructured":"Canadian Cancer Society. Survival statistics for prostate cancer. Toronto (ON); 2023 [updated 2023 Aug; 2025 Apr 21]. Available from: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/prostate\/prognosis-and-survival\/survival-statistics"},{"key":"e_1_3_9_17_1","unstructured":"Canadian Cancer Society. Survival statistics for breast cancer. Toronto (ON); 2023 [updated 2023 Aug; cited 2025 Apr 21]. Available from: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/breast\/prognosis-and-survival\/survival-statistics"},{"key":"e_1_3_9_18_1","unstructured":"Canadian Cancer Society. Survival statistics for thyroid cancer. Toronto (ON); [cited 2025 Apr 21]. Available from: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/thyroid\/prognosis-and-survival\/survival-statistics"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1995080218050141"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0260"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02650-y"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2009.32"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2001.118370"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2017.03.80"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00211-0"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170317"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211065471"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/2381468319852332"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02676-2"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.09.044"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.08.008"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1222907"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113432"},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S317627"},{"key":"e_1_3_9_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31529"},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1615886"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0401-1"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60751-4"},{"key":"e_1_3_9_39_1","unstructured":"Statistics Canada. Life tables Canada provinces and territories 1980\/1982 to 2018\/2020 (three-year estimates) and 1980 to 2020 (single-year estimates). Ottawa (ON); 2022 [updated 2022 Jan 24; cited 2023 Apr 9]. Available from: https:\/\/www150.statcan.gc.ca\/n1\/pub\/84-537-x\/84-537-x2021001-eng.htm"},{"key":"e_1_3_9_40_1","unstructured":"Rutherford MJ Lambert PC Sweeting MJ et al. National institute for health and care excellence decision support unit (NICE DSU) technical support document 21. Flexible methods for survival analysis [Internet]. London (UK); 2020 [cited 2025 Apr 21]. Available from: https:\/\/www.sheffield.ac.uk\/nice-dsu\/tsds\/survival-analysis"},{"key":"e_1_3_9_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_9_42_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6376"},{"key":"e_1_3_9_43_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2016.57.5.1165"},{"key":"e_1_3_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14062"},{"key":"e_1_3_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009625.pub2"},{"key":"e_1_3_9_46_1","doi-asserted-by":"crossref","unstructured":"Dahm P Brasure M Ester E et al. Therapies for clinically localized prostate cancer [internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 [cited 2025 Apr 21]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562484\/","DOI":"10.23970\/AHRQEPCCER230"},{"key":"e_1_3_9_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000481438"},{"key":"e_1_3_9_48_1","unstructured":"The government of United Kingdom. Cost consequence analysis. London (UK). [updated July 22 2020; cited 2025 Apr 21]. Available from: https:\/\/www.gov.uk\/guidance\/cost-consequence-analysis-health-economic-studies"},{"key":"e_1_3_9_49_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462319000576"},{"issue":"2","key":"e_1_3_9_50_1","first-page":"1","article-title":"United States life tables, 2022","volume":"74","author":"Arias E","year":"2025","unstructured":"Arias E, Xu J, Kochanek K. United States life tables, 2022. Natl Vital Stat Rep. 2025;74(2):1\u201364.","journal-title":"Natl Vital Stat Rep"}],"container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2025.2522326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:17:56Z","timestamp":1756725476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2025.2522326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8,9]]}},"alternative-id":["10.1080\/14737167.2025.2522326"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2025.2522326","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}